scholarly article | Q13442814 |
P356 | DOI | 10.1126/SCIENCE.172.3979.165 |
P698 | PubMed publication ID | 5547729 |
P2093 | author name string | Rosenfeld R | |
Pitt CG | |||
Wall ME | |||
Boegli G | |||
Brine DR | |||
Christensen HD | |||
Freudenthal RI | |||
Gidley JT | |||
Testino L | |||
P433 | issue | 3979 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | tetrahydrocannabinol | Q190067 |
cannabinoids | Q422936 | ||
P304 | page(s) | 165-167 | |
P577 | publication date | 1971-04-01 | |
P1433 | published in | Science | Q192864 |
P1476 | title | Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse | |
P478 | volume | 172 |
Q70622527 | (−)-Δ8-tetrahydrocannabinol: Two novel in vitro metabolites |
Q72851276 | 3H-Δ9-tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: Penetration and regional distribution in rat brain |
Q67237200 | 6β-Hydroxy-Δ 1 -Tetrahydrocannabinol Synthesis and Biological Activity |
Q48771308 | 9 -Tetrahydrocannabinol and its metabolites in monkey brains |
Q41321274 | ?9-Tetrahydrocannabinol and the extrapyramidal system |
Q51310997 | A comparison of the pharmacological activity of delta 9-tetrahydrocannabinol and its monohydroxylated metabolites in man. |
Q39994532 | A metabolic interactionin vivobetween cannabidiol and Δ1-tetrahydrocannabinol |
Q40302560 | Alterations in Murine Delayed Type Hypersensitivity Responses by Delta-8-THC and Cannabinol |
Q39707852 | Behavioral and electroencephalographic correlates of the chronic use of marijuana—A review |
Q43974420 | Biochemical changes in rat testicular cells in vitro produced by cannabinoids and alcohol: metabolism and incorporation of labeled glucose, amino acids, and nucleic acid precursors |
Q52322755 | Blood levels of 3H-Δ9-tetrahydrocannabinol and its metabolites in tolerant and nontolerant pigeons |
Q43002102 | Brain levels of Δ1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of Δ1-tetrahydrocannabinol |
Q46373604 | Brain microsomal oxidation of delta 8- and delta 9-tetrahydrocannabinol |
Q48214375 | Cannabinoid effects on plasma corticosterone and uptake of 3H-corticosterone by mouse brain |
Q38605328 | Cannabis Use during Pregnancy: Pharmacokinetics and Effects on Child Development |
Q39827523 | Cannabis and the brain with special reference to the limbic system |
Q39927063 | Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injections of delta 9-tetrahydrocannabinol |
Q39796895 | Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats |
Q43408201 | Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats |
Q24634172 | Comparative pharmacology of Delta9-tetrahydrocannabinol and its metabolite, 11-OH-Delta9-tetrahydrocannabinol |
Q72852839 | Comparison in mice of pharmacological effects of Δ8-tetrahydrocannabinol and its metabolites oxidized at 11-position |
Q48970177 | Cross-tolerance development to the prolongation of pentobarbitone-induced sleep by delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice |
Q48686999 | Delta-9-Tetrahydrocannabinol: Localization in Body Fat |
Q70516837 | Delta-9-Tetrahydrocannabinol: Metabolism and Disposition in Long-Term Marihuana Smokers |
Q66980591 | Delta-9-tetrahydrocannabinol uptake by adipose tissue: Preferential accumulation in gonadal fat organs |
Q69643672 | Development of tolerance to delta9-THC in the frog |
Q36176523 | Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. |
Q39122769 | Dioxygenated metabolites of cannabidiol formed by rat liver |
Q35174467 | Distribution of Δ9-tetrahydrocannabinol in the mouse |
Q48431703 | Distribution studies of [14C]delta-9-tetrahydrocannabinol in mice: Effect of vehicle, route of administration, and duration of treatment |
Q37238136 | Drug disposition in the mammalian eye and brain: a comparison of mechanisms |
Q69589003 | EEG and behavioral effects of natural, synthetic and biosynthetic cannabinoids |
Q44478808 | Effects of 7-Hydroxy-Δ6-Tetrahydrocannabinol and Some Related Cannabinoids on the Guinea Pig Isolated Ileum |
Q39854595 | Effects of Cannabinoids on Synaptic Membrane Enzymes. I.In vitroStudies on Synaptic Membranes Isolated from Rat Brain |
Q67297991 | Effects of cannabis resin on social behaviour in the laboratory mouse |
Q70755601 | Evidence for a caudal brainstem site of action for cannabinoid induced hypothermia |
Q37650292 | Examining the roles of cannabinoids in pain and other therapeutic indications: a review |
Q66702192 | Guide to urine testing in drug abuse prevention and multimodality treatment programs |
Q69654144 | Hypothermic action of Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-hydroxy-Δ8-tetrahydrocannabinol in mice |
Q40268245 | Immunosuppression by marihuana and its cannabinoid constituents |
Q41034566 | Influence of fasting on the absorption and effects of δ9-tetrahydrocannabinol after oral administration in sesame oil |
Q35601052 | Interaction of cannabis and general anaesthetic agents in mice |
Q39886185 | Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse |
Q51317642 | Intravenous Injection in Man of Δ 9 -Tetrahydrocannabinol and 11-OH-Δ 9 -Tetrahydrocannabinol |
Q67359829 | Marihuana-like activity of new synthetic tetrahydrocannabinols |
Q92169824 | Marijuana Use in Pregnancy: A Review |
Q48646469 | Metabolism and distribution of cannabinoids in rats after different methods of administration |
Q69813967 | Metabolism of Δ1-Tetrahydrocannabinol by Mouse Hepatic Microsomes: Identification of 6α-Hydroxytetrahydrocannabinol |
Q40314977 | Metabolism of Δ1-tetrahydrocannabinol by the rat in vivo and in vitro |
Q38717316 | Metabolomics of Δ9-tetrahydrocannabinol: implications in toxicity |
Q39255597 | Microsomal oxygenase catalyzed oxidation of 11-hydroxy-Δ8-tetrahydrocannabinol to 11-oxo-Δ8-tetrahydrocannabinol |
Q68927847 | Modification of ?9-THC-actions by cannabinol and cannabidiol in the rat |
Q69375353 | Oral and Parenteral Formulations of Marijuana Constituents |
Q69829953 | Oxygenation mechanism in the oxidation of xenobiotic aldehyde to carboxylic acid by mouse hepatic microsomes |
Q44084405 | Perfusion of the isolated rat brain with [14C]-Δ1-tetrahydrocannabinol |
Q44070866 | Physiochemical and pharmacological characterization of a Delta(9)-THC aerosol generated by a metered dose inhaler |
Q40120568 | Prenatal exposure to cannabis: A critical review of effects on growth, development, and behavior |
Q39881433 | Psychopharmacology of the cannabinoids. A review |
Q47933889 | Relating Observed Psychoactive Effects to the Plasma Concentrations of Delta-9-Tetrahydrocannabinol and Its Active Metabolite: An Effect-Compartment Modeling Approach |
Q44052866 | Studies on the effects of Δ1-tetrahydrocannabinol (Δ1-THC) and DDT on the hepatic microsomal metabolism of Δ1-THC and other compounds in the rat |
Q67018774 | The course of aggressive behavior induced by a single injection of Δ9-Tetrahydrocannabinol and its characteristics |
Q52327635 | The delay of the behavioral effects of Δ9-tetrahydrocannabinol in rats by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) |
Q44668707 | The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection |
Q67245660 | The effect of cannabinol delta1-tetrahydro-cannabinol clearance from the blood |
Q69389310 | The effect of pre-natal Cannabis Sativa on maze learning ability in the rat |
Q39941262 | The metabolism of the tetrahydrocannabinols |
Q39956537 | The psychopharmacology of ‘Cannabis sativa’: A review |
Q39999152 | The ring test: a quantitative method for assessing the ‘cataleptic’ effect of cannabis in mice |
Q43968817 | The uptake and metabolic fate of cannabinoids in rat brains |
Q48382168 | The uptake ofΔ9-tetrahydrocannabinol in choroid plexus and brain cortexin vitro andin vivo |
Q85125678 | Δ9-Tetrahydrocannabinol and Its Major Metabolite Δ9-Tetrahydrocannabinol-11-oic Acid as 15-Lipoxygenase Inhibitors |
Search more.